about
Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological TreatmentsProtocol Evaluating the effectiveness of a school-based group programme for parents of children at risk of ADHD: the 'PArents, Teachers and CHildren WORKing Together (PATCHWORK)' cluster RCT protocolTask-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate.Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysisEffectiveness and cost-effectiveness of a brief school-based group programme for parents of children at risk of ADHD: a cluster randomised controlled trialEfficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysisCardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort.A qualitative process evaluation of electronic session-by-session outcome measurement in child and adolescent mental health servicesAnnual Research Review: Digital health interventions for children and young people with mental health problems - a systematic and meta-review.Association of measures of fetal and childhood growth with non-clinical psychotic symptoms in 12-year-olds: the ALSPAC cohort.The use of routine outcome measures in two child and adolescent mental health services: a completed audit cycleCortical gray matter in attention-deficit/hyperactivity disorder: a structural magnetic resonance imaging studyEffects of motivation and medication on electrophysiological markers of response inhibition in children with attention-deficit/hyperactivity disorder.Evaluating the effectiveness of a schools-based programme to promote exercise self-efficacy in children and young people with risk factors for obesity: steps to active kids (STAK).Developmental language disorders--a follow-up in later adult life. Cognitive, language and psychosocial outcomes.European guidelines on managing adverse effects of medication for ADHD.Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review.Transition to adult mental health services for young people with attention deficit/hyperactivity disorder (ADHD): a qualitative analysis of their experiences.Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD-'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlEnhanced cognitive control in Tourette Syndrome during task uncertainty.Compensatory neural reorganization in Tourette syndrome.'Mind the gap'--mapping services for young people with ADHD transitioning from child to adult mental health servicesThe Normal Inhibition of Associations is Impaired by Clonidine in Tourette Syndrome.The quality of life of children with attention deficit/hyperactivity disorder: a systematic review.Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study.Driving behaviour in adults with attention deficit/hyperactivity disorder.Towards an understanding of unique and shared pathways in the psychopathophysiology of ADHD.Recommendations for the transition of patients with ADHD from child to adult healthcare services: a consensus statement from the UK adult ADHD network.Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach.Motor excitability is reduced prior to voluntary movements in children and adolescents with Tourette syndrome.Developing mHealth Remote Monitoring Technology for Attention Deficit Hyperactivity Disorder: A Qualitative Study Eliciting User Priorities and Needs.Morphological abnormalities in prefrontal surface area and thalamic volume in attention deficit/hyperactivity disorder.Antecedents of Attention-Deficit/Hyperactivity Disorder Symptoms in Children Born Extremely Preterm.Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale.Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder.Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system.Implementation of routine outcome measurement in child and adolescent mental health services in the United Kingdom: a critical perspective.NICE guideline: attention deficit hyperactivity disorder.
P50
Q22241854-39665BA4-DA9F-4C70-AA09-E40790BE04DCQ24121283-3CA396E1-4762-43E4-8A58-995B47CD620CQ27349250-07EBCBD9-F26A-4A98-885C-BFB98199A98DQ28066380-26C8B08C-3083-4FAB-8DD4-8CD5DDA8A8D6Q28321107-EF114B15-CC6F-465E-AEB3-4EDCD843B54BQ28650054-CC90F2B4-CEA6-4F14-A79F-34445D4F1450Q30399107-36E0C2EE-CA9A-48FE-B0C8-6068067954ABQ30492782-574E5FC4-8D35-43CC-B09B-2416212406A1Q30578082-654ACE34-F21C-45EB-B4F4-B0AE4D2A1AD6Q33451838-31DDAF83-C09B-4AF4-8FEB-166140A568E1Q33575189-BF75F450-6E94-4DB1-B1A5-8B4A23C4FE97Q33590015-6D9EA374-937C-418F-AA00-38F20222A4B2Q33690481-F57A9577-370E-44DC-9146-B3C9D6F258FAQ33754250-9D1B195B-465C-43DA-A0AB-860181E590CBQ34059025-FE5F6199-DE3C-423D-8EB8-139B2E7A95B2Q34389276-07261C8F-B3BA-4D63-8C50-441E6E3C67BCQ34448884-11B3C3E0-882C-4764-AFEF-685541223CE5Q34524415-F94903ED-6642-4994-8398-5349D79BAC92Q34622478-605382D9-80F5-4D95-955A-24A2A8B66F12Q34635231-6C1F5062-EAB7-4402-B88B-3621609AAE8EQ34637548-9D4CB3C9-88F0-4C34-BA32-1F099F5DCF6CQ34792914-AB5B846F-20CD-4C8F-89D1-3C44ADFEC3A5Q34810199-DEF0E6A7-AE09-43FA-BB84-C79CA8157787Q34900859-DB7E9FFB-5DC5-4774-93BE-339E55362A92Q35084047-5BBDBED5-E490-4427-97A0-A5414AA7EC24Q35176940-E799EBD3-DA76-4721-857F-09374F6684F7Q35717795-E8E1201B-BA43-4760-B4C6-12AB615069C6Q36048613-619CB86F-FD12-4D9A-B648-33C16C845198Q36113283-C52C7485-545C-4D6B-94C9-473A555E16B5Q36276018-1DC310DF-258F-423F-9C4D-C398BD85B719Q36745011-A530B9A5-ADD9-418A-A22C-6E4978736530Q36773697-58317BE3-152A-4FD2-BF4F-262DC76CDE32Q36806119-780F3517-7B84-4950-9AFC-BCD18B9D573CQ36854810-9220BCCB-40BD-44FF-BF3C-91C4AA0D4828Q36861122-513104A5-AC14-48B1-A3F8-6B55379B949DQ37190637-11CFF118-DB53-4A45-A5EC-3C837C35BCE2Q37253463-3E220EFE-6A04-4159-9847-4B61E7359CB5Q37648289-766F4974-7E41-40E3-A6B8-3A387F8AC97EQ37681313-5225C887-04DE-4B3C-B0BB-F944E359746AQ37690047-59BF6FAD-420A-44ED-B4B0-909AA2E715AC
P50
description
British psychiatrist
@en
British psychiatrist
@en-ca
British psychiatrist
@en-gb
Brits psychiater
@nl
psichiatra britannico
@it
psikiatra britainiarra
@eu
psiquiatra británico
@es
psiquiatra británico
@gl
psiquiatra británicu
@ast
psiquiatra britânico
@pt
name
Chris Hollis
@ast
Chris Hollis
@ca
Chris Hollis
@en
Chris Hollis
@es
Chris Hollis
@fr
Chris Hollis
@nl
Chris Hollis
@sl
type
label
Chris Hollis
@ast
Chris Hollis
@ca
Chris Hollis
@en
Chris Hollis
@es
Chris Hollis
@fr
Chris Hollis
@nl
Chris Hollis
@sl
prefLabel
Chris Hollis
@ast
Chris Hollis
@ca
Chris Hollis
@en
Chris Hollis
@es
Chris Hollis
@fr
Chris Hollis
@nl
Chris Hollis
@sl
P106
P21
P31
P496
0000-0003-1083-6744